Meltz Mark A 4
4 · Kinnate Biopharma Inc. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
Meltz Mark A
COO General Counsel Treasurer
Transactions
- Tax Payment
Common Stock
2023-12-01$2.25/sh−541$1,217→ 28,136 total
Footnotes (2)
- [F1]The shares were forfeited to cover a tax obligation resulting form the quarterly vesting of restricted stock units ("RSUs") granted to the Reporting Person by the Issuer.
- [F2]Includes 17,188 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date.